First-in-Human Phase I/II Study of NEOD001 in Patients With Light Chain Amyloidosis and Persistent Organ DysfunctionMorie A. Gertz, Michaela Liedtke, David C. Seldin et al.|Journal of Clinical Oncology|2016Cited by 206